Aims With the success of antiretroviral therapy (ART), non-human immunodeficiency virus
(HIV)-related comorbidities like cardiovascular diseases (CVDs) are of increasing concern …

Abnormalities in lipid metabolism are very commonly observed in patients who are obese.
Approximately 60-70% of patients with obesity are dyslipidemic. The lipid abnormalities in …

Importance Whether people infected with human immunodeficiency virus (HIV) are at an
increased risk of acute myocardial infarction (AMI) compared with uninfected people is not …

Background: Neck circumference, a proxy for upper-body sc fat, may be a unique fat depot
that confers additional cardiovascular risk above and beyond central body fat. Methods and …

Background Aim of this review is to focus the attention on people living with HIV infection at
risk of developing a cardiovascular event. What is or what would be the most suitable …

Background: Cardiovascular disease (CVD) is an increasing cause of morbidity and
mortality in HIV-infected patients. However, it is controversial whether HIV infection …

Combination antiretroviral therapy (cART) against HIV infection dramatically reduces AIDS-
related morbidity. However, many patients under cART display HIV-associated …

Background: As HIV-infected persons age, the relative contribution of HIV infection,
combination antiretroviral therapy (cART), and the normal aging process to the frequent …

As antiretroviral therapy has decreased human immunodeficiency virus (HIV)–associated
mortality, cardiometabolic abnormalities have become increasingly apparent in HIV-infected …

Owing to the advent of antiretroviral (ART) drugs, human immunodeficiency virus (HIV) has
become a controllable infection, but pernicious health outcomes due to the infection are …